Ultravate

— THERAPEUTIC CATEGORIES —
  • Psoriasis

Ultravate Generic Name & Formulations

General Description

Halobetasol propionate 0.05%; lotion.

Pharmacological Class

Corticosteroid.

How Supplied

Lotion—60mL

Generic Availability

YES

Ultravate Indications

Indications

Plaque psoriasis.

Ultravate Dosage and Administration

Adult

≥18yrs: apply thin layer to affected areas twice daily for up to max 2 weeks; max 50g/week. Discontinue when control is achieved. Do not occlude.

Children

<18yrs: not established.

Ultravate Contraindications

Not Applicable

Ultravate Boxed Warnings

Not Applicable

Ultravate Warnings/Precautions

Warnings/Precautions

Not for oral, ophthalmic, or intravaginal use. Avoid use on the face, scalp, groin, or axillae. Risk of HPA axis suppression with high-potency corticosteroids, prolonged use, application to large surface areas, occlusive use, altered skin barrier, concomitant multiple corticosteroid-containing products, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue until resolved. Reevaluate periodically. Pregnancy. Nursing mothers: avoid nipple/areola area due to infant exposure.

Ultravate Pharmacokinetics

See Literature

Ultravate Interactions

Not Applicable

Ultravate Adverse Reactions

Adverse Reactions

Telangiectasia, application site atrophy, headache; allergic contact dermatitis (discontinue if occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia, glucosuria.

Ultravate Clinical Trials

See Literature

Ultravate Note

Not Applicable

Ultravate Patient Counseling

See Literature